Human BCMA (Luc) HEK293 Reporter Cell

사용자 리뷰
제품 번호/규격
가격
수량
CHEK-ATF296-2Vials (1Vial X 2)
$15220.00
ETA of in-stock products:2 business days
총 항목 수 제품 금액$ 0

제품 세부정보

    1. Genetically modified cell lines best reflect MOA (Mechanism of Action)
    2. Higher activity and larger assay window for robust and reproducible cell-based bioassay
    3. Comprehensive application data to support assay development and validation
    4. Full tracible record, stringent quality control and validated cell passage stability
    5. Parental cell line legally obtained from internationally recognized cell resource bank and commercially licensed
    6. Global commercial license assistance whenever regulatory filing is required
  • Description

    The Human BCMA (Luc) HEK293 Reporter Cell was engineered to not only express NF-κB signaling response element, but also express the receptor full length human BCMA (Uniprot: Q02223-1). When stimulated with human APRIL or BAFF protein, receptor-mediated signaling can drive NF-κB-mediated luminescence. Neutralization of biological effect of the ligand-receptor interaction by corresponding antibody results in a decrease in luminescence.

  • Application

    • Screen for neutralizing antibodies blocking the stimulation of human APRIL or BAFF protein

    BCMA Assay Principles

  • Growth Properties

    Adherent

  • Selection Marker

    Puromycin (2 μg/mL) + G418 (200 μg/mL)

  • Complete Growth Medium

    DMEM + 10% FBS

  • Freeze Medium

    Serum-free cell cryopreservation medium

  • Quantity

    1 vial contains at least 5×10^6 cells in 1 mL serum-free cryopreservation medium

  • Storage

    Frozen in liquid nitrogen.

  • Mycoplasma Testing

    Negative

  • Sterility Testing

    Negative

  • Instructions for Use

    See data sheet for detailed culturing and assay protocol.

  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

고객님도 확인한 상품

데이터 표시

  • Receptor Assay

     BCMA FACS

    Expression analysis of human BCMA on Human BCMA (Luc) HEK293 Reporter Cell by FACS.
    Cell surface staining was performed on Human BCMA (Luc) HEK293 Reporter Cell or negative control cell using PE-labeled anti-human BCMA antibody.

    Protocol
  • Application

     BCMA APPLICATION

    Inhibition of human APRIL protein-induced reporter activity by anti-human APRIL neutralizing antibody.
    The Human BCMA (Luc) HEK293 Reporter Cell was incubated with serial dilutions of antibodies in the presence of human APRIL protein (Cat. No. APL-H52D1) with a final concentration of 0.08 μg/mL. The EC50 of anti-human APRIL neutralizing antibody is approximately 0.14 μg/mL.

    Protocol
  •  BCMA APPLICATION

    Inhibition of human BAFF protein-induced reporter activity by anti-human BAFF neutralizing antibody.
    The Human BCMA (Luc) HEK293 Reporter Cell was incubated with serial dilutions of antibodies in the presence of human BAFF protein (Cat. No. BAF-H52D4) with a final concentration of 0.6 μg/mL. The EC50 of anti-human BAFF neutralizing antibody is approximately 0.13 μg/mL.

    Protocol
  •  BCMA APPLICATION

    Inhibition of human BAFF protein-induced reporter activity by anti-human BCMA neutralizing antibody.
    The Human BCMA (Luc) HEK293 Reporter Cell was incubated with serial dilutions of antibodies in the presence of human BAFF protein (Cat. No. BAF-H52D4) with a final concentration of 0.6 μg/mL. The EC50 of anti-human BCMA neutralizing antibody is approximately 0.34 μg/mL.

    Protocol
  • Signaling Bioassay

     BCMA SIGNALING

    Response to human APRIL protein (RLU).
    The Human BCMA (Luc) HEK293 Reporter Cell was stimulated with serial dilutions of human APRIL protein (Cat. No. APL-H52D1). The EC50 was approximately 0.04 μg/mL.

    Protocol
  •  BCMA SIGNALING

    Response to human APRIL protein (FOLD).
    The Human BCMA (Luc) HEK293 Reporter Cell was stimulated with serial dilutions of human APRIL protein (Cat. No. APL-H52D1). The max induction fold was approximately 33.37.

    Protocol
  •  BCMA SIGNALING

    Response to human BAFF protein (RLU).
    The Human BCMA (Luc) HEK293 Reporter Cell was stimulated with serial dilutions of human BAFF protein (Cat. No. BAF-H52D4). The EC50 was approximately 0.79 μg/mL.

    Protocol
  •  BCMA SIGNALING

    Response to human BAFF protein (FOLD).
    The Human BCMA (Luc) HEK293 Reporter Cell was stimulated with serial dilutions of human BAFF protein (Cat. No. BAF-H52D4). The max induction fold was approximately 27.90.

    Protocol
*Please contact us if you are interested in related cell pool service.

사용자 리뷰
댓글 남기기

중요 성명

  • LIMITED USE AND LICENSE STATEMENT

    HEK293 Cell Line Products

    By using any HEK293 cell line product purchased from ACRO Biosystems or its affiliates (collectively, "ACROBiosystems"), including the original 293 cells and any modified derivatives thereof (collectively, the "Product"), you (the "Customer") agree to be bound by the following terms of limited use. If you are not willing to accept these terms and the Product remains unused, please contact our customer service at customerservice@acrobiosystems.com to arrange for return of the unused Product for a refund.

    • 1. Scope of Use

      For the use of the Product worldwide (excluding Mainland China, Hong Kong, Macao and Taiwan regions), Customer may use the Product for (i) internal research; (ii) drug discovery and assay development; (iii) internal quality assurance testing for biologic drugs and vaccines; and (iv) lot releasing assay for biologic drugs and vaccines, whether conducted by a commercial or non-commercial entity. Unless a separate sublicense has been obtained, it is NOT permitted to use the Product in (i) product manufacturing; (ii) provision of service, information, or data to an unaffiliated third party for a fee; (iii) resale of the Product or its derivatives, whether or not such Product or derivatives are resold for use in research or (iv) other commercial use not expressly permitted above.


      For the use of the Product in Greater China region (including Mainland China, Hong Kong, Macao and Taiwan regions), Customer may use the Product for internal research use only. Unless a separate sublicense has been obtained, it is NOT permitted to use the Product for any Commercial Use. For the purpose of this paragraph, "Commercial Use" means any and all uses of this product and derivatives by a party for profit or other consideration and may include but is not limited to use in: (i) product manufacture; (ii) provision of service, information or data to a third party for a fee; (iii) resale of the product or its derivatives, whether or not such Product or derivatives are resold for use in research; (iv) quality assurance testing for biologic drugs and vaccines; (v) quality control assays; (vi) lot releasing assay of biologic drugs and vaccines.


      If you require a sublicense for any use beyond the limited use permitted herein, including but not limited to commercial use, CRO/service provider activities for a fee, or any product manufacturing activities, please contact the local sales team of ACROBiosystems for further details.


      The Product is not intended for any animal or human therapeutic purposes, nor for any direct human in vivo use. The Product shall not be used in or administered to humans.

    • 2. Transfer, Distribution and Sublicensing Restrictions

      Unless expressly permitted under a separate written agreement with/via ACROBiosystems, you have NO right to (i) share, transfer, distribute, sell, resell, sublicense, or otherwise make the Product or its derivatives available for use to any third party, including but not limited to other researchers, laboratories, departments, research institutions, hospitals, universities, contract research organizations (CROs), contract development and manufacturing organizations (CDMOs), or any other commercial entities; or (ii) use the Product or its derivatives to perform fee-for-service activities or to provide services, information, or data to any third party for monetary or other consideration.

    • 3. Modification and Derivatives

      Customers have No right to modify, engineer, genetically alter, or create derivatives of the Product. Any such modification or derivative requires a separate license and additional fees. Please contact our local sales team for further details.

    • 4. No Warranty

      ACROBiosystems makes no warranties or representations of any kind, either expressed or implied, with respect to the merchantability, fitness or suitability of the Product for any particular purpose.

    • 5. Limitation of Liability

      To the fullest extent permitted by law, in no event shall ACROBiosystems or its licensors be liable for any use by Customer of the Product, any derivative thereof, or any material treated therewith for any losses, costs, claims, damages, or liability of whatsoever kind or nature which may arise from or in connection with the use of the Product.

    • 6. Compliance with Laws

      Customer agrees to use the Product in compliance with all applicable laws, regulations, and governmental guidelines applicable to the Product, any derivative thereof, and any materials treated therewith.

    ACKNOWLEDGMENT

    By using this Product, Customer acknowledges that he/she has read, understood, and agreed to be bound by the terms and conditions of this Limited Use and License Statement. If Customer does not agree to comply with these terms, Customer shall not open or use the Product and shall contact ACROBiosystems to arrange for return of the unused Product.

프론티어 진행

 
의약품 개발 진행
  • 영어 이름:

    B-cell maturation protein

  • 카테고리:

  • 상장 의약품 수:

    8 상세

  • 임상 의약품 수:

    145 상세

  • 최고 개발 단계:

    Approved

연락하기
신약 후보물질 라이선싱
더 많이 알아보기
  • 기본 제품 정보
  • 제품 세부정보
  • 고객님도 확인한 상품
  • 데이터 표시
  • 사용자 리뷰
  • 중요 성명
문의하기

전화
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521

주소 서울특별시 송파구 법원로11길 11, 제3층 제비-314,315호